Blog post yesterday.Biostrand, which is IPAs wholly owned AI division, announced that it's AI (silico) can match the standard wet lab (vivo) in drug discovery!! Biostrand can reduce the time it takes for a new drug discovery by 2-3 years and cut costs by $100 million or more.
Bold statements? Results from collaborations over the past 12-18 months with large Pharmaceutical Co's are expected shortly. "Astellas" (Japan) a $100 billion+ world wide Pharma company is expected to make the first announcement. A win/win for all patients and everyone involved in this exciting breakthrough. Congratulations!